<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD000176" GROUP_ID="PREG" ID="257199081020101765" MERGED_FROM="" MODIFIED="2012-08-08 09:38:29 +0100" MODIFIED_BY="Sonja Henderson" NOTES="&lt;p&gt;Short title (no longer in use): Amnioinfusion prophylactically vs therapeutically&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2012-08-08 09:36:16 +0100" NOTES_MODIFIED_BY="Sonja Henderson" REVIEW_NO="0035" REVMAN_SUB_VERSION="5.1.7" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="9.0">
<COVER_SHEET MODIFIED="2012-08-08 09:38:29 +0100" MODIFIED_BY="Sonja Henderson">
<TITLE>Prophylactic versus therapeutic amnioinfusion for oligohydramnios in labour</TITLE>
<CONTACT MODIFIED="2012-08-08 09:38:29 +0100" MODIFIED_BY="Sonja Henderson"><PERSON ID="15917" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>G Justus</FIRST_NAME><LAST_NAME>Hofmeyr</LAST_NAME><POSITION>Director/Hon. Professor, Effective Care Research Unit</POSITION><EMAIL_1>justhof@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology, East London Hospital Complex</DEPARTMENT><ORGANISATION>University of the Witwatersrand, University of Fort Hare, Eastern Cape Department of Health</ORGANISATION><ADDRESS_1>Frere and Cecilia Makiwane Hospitals</ADDRESS_1><ADDRESS_2>Private Bag X 9047</ADDRESS_2><CITY>East London</CITY><ZIP>5200</ZIP><REGION>Eastern Cape</REGION><COUNTRY CODE="ZA">South Africa</COUNTRY><PHONE_1>+27 43 7092483</PHONE_1><PHONE_2>+27 83 2809402</PHONE_2><FAX_1>+27 43 7092483</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2012-08-08 09:38:29 +0100" MODIFIED_BY="Sonja Henderson"><PERSON ID="76315EC182E26AA201AA8B424157761B" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Natalia</FIRST_NAME><LAST_NAME>Novikova</LAST_NAME><EMAIL_1>novikovanatalia@gmail.com</EMAIL_1><MOBILE_PHONE>+27796807821</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology, East London Hospital Complex</DEPARTMENT><ORGANISATION>Walter Sisulu University</ORGANISATION><ADDRESS_1>Private Bag X9047</ADDRESS_1><CITY>East London</CITY><ZIP>5200</ZIP><COUNTRY CODE="ZA">South Africa</COUNTRY><PHONE_1>+27796807821</PHONE_1><FAX_1>+27865418347</FAX_1></ADDRESS></PERSON><PERSON ID="15917" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>G Justus</FIRST_NAME><LAST_NAME>Hofmeyr</LAST_NAME><POSITION>Director/Hon. Professor, Effective Care Research Unit</POSITION><EMAIL_1>justhof@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology, East London Hospital Complex</DEPARTMENT><ORGANISATION>University of the Witwatersrand, University of Fort Hare, Eastern Cape Department of Health</ORGANISATION><ADDRESS_1>Frere and Cecilia Makiwane Hospitals</ADDRESS_1><ADDRESS_2>Private Bag X 9047</ADDRESS_2><CITY>East London</CITY><ZIP>5200</ZIP><REGION>Eastern Cape</REGION><COUNTRY CODE="ZA">South Africa</COUNTRY><PHONE_1>+27 43 7092483</PHONE_1><PHONE_2>+27 83 2809402</PHONE_2><FAX_1>+27 43 7092483</FAX_1></ADDRESS></PERSON><PERSON ID="62B7F5F182E26AA20187B796FDDA732A" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>George</FIRST_NAME><LAST_NAME>Essilfie-Appiah</LAST_NAME><POSITION>Consultant Obstetrician/Gynaecologist</POSITION><EMAIL_1>essilfieappiah@hotmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>Nelson Mandela Academic Hospital and Walter Sisulu University</ORGANISATION><CITY>Mthanta</CITY><COUNTRY CODE="ZA">South Africa</COUNTRY><PHONE_1>+27 43 7082120</PHONE_1><PHONE_2>+27 43 7228692</PHONE_2><FAX_1>+27 43 7228692</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2012-08-08 09:30:00 +0100" MODIFIED_BY="Sonja L  Henderson">
<UP_TO_DATE>
<DATE DAY="8" MONTH="8" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="28" MONTH="2" YEAR="2012"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="31" MONTH="8" YEAR="2013"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="1995"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="1995"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="1996"/>
</DATES>
<WHATS_NEW MODIFIED="2012-08-08 09:29:26 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2012-08-08 09:29:26 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="23" MONTH="7" YEAR="2012"/>
<DESCRIPTION>
<P>Search updated in February 2012.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2012-07-23 16:54:55 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="23" MONTH="7" YEAR="2012"/>
<DESCRIPTION>
<P>Review updated. No new trials identified.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2012-07-23 16:54:25 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2012-07-23 16:54:25 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="7" YEAR="2010"/>
<DESCRIPTION>
<P>Contact details edited.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2010-07-02 12:04:08 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="15" MONTH="5" YEAR="2010"/>
<DESCRIPTION>
<P>One previously included study has now been excluded (<LINK REF="STD-Cook-1993" TYPE="STUDY">Cook 1993</LINK>).</P>
<P>Search updated. No new studies identified. Studies previously awaiting classification (<LINK REF="REF-Abdel_x002d_Aleem-2005" TYPE="REFERENCE">Abdel-Aleem 2005</LINK>; <LINK REF="REF-Amin-2003" TYPE="REFERENCE">Amin 2003</LINK>; <LINK REF="REF-Persson_x002d_Kjerstadius-1999" TYPE="REFERENCE">Persson-Kjerstadius 1999</LINK>; <LINK REF="REF-Puertas-2001" TYPE="REFERENCE">Puertas 2001</LINK>; <LINK REF="REF-Rinehart-2000" TYPE="REFERENCE">Rinehart 2000</LINK>) were not included as they are more suitable for another review 'Amnioinfusion for potential or suspected umbilical cord compression in labour' (<LINK REF="REF-Hofmeyr-1998" TYPE="REFERENCE">Hofmeyr 1998</LINK>).</P>
<P>Two new authors joined the review team.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-05-25 14:56:36 +0100" MODIFIED_BY="Lynn Hampson">
<DATE DAY="3" MONTH="8" YEAR="2009"/>
<DESCRIPTION>
<P>Search updated. Five reports added to <LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK> (<LINK REF="REF-Abdel_x002d_Aleem-2005" TYPE="REFERENCE">Abdel-Aleem 2005</LINK>; <LINK REF="REF-Amin-2003" TYPE="REFERENCE">Amin 2003</LINK>; <LINK REF="REF-Persson_x002d_Kjerstadius-1999" TYPE="REFERENCE">Persson-Kjerstadius 1999</LINK>; <LINK REF="REF-Puertas-2001" TYPE="REFERENCE">Puertas 2001</LINK>; <LINK REF="REF-Rinehart-2000" TYPE="REFERENCE">Rinehart 2000</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-08-03 22:36:08 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="12" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-11-12 11:18:14 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="30" MONTH="10" YEAR="2001"/>
<DESCRIPTION>
<P>Search updated. No new studies found.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>University of Witwatersrand</NAME>
<COUNTRY CODE="ZA">South Africa</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>South African Medical Research Council</NAME>
<COUNTRY CODE="ZA">South Africa</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>UNDP/UNFPA/WHO/World Bank (HRP)</NAME>
<COUNTRY CODE="CH">Switzerland</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2012-08-08 09:36:16 +0100" MODIFIED_BY="Sonja L  Henderson">
<SUMMARY MODIFIED="2010-06-04 10:06:56 +0100" MODIFIED_BY="Sonja L  Henderson">
<TITLE MODIFIED="2010-06-04 10:06:56 +0100" MODIFIED_BY="Sonja L  Henderson">Prophylactic versus therapeutic amnioinfusion for oligohydramnios in labour</TITLE>
<SUMMARY_BODY MODIFIED="2010-06-03 16:57:46 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>Amnioinfusion can help when a baby is surrounded by too little fluid in the womb (oligohydramnios) and is showing distress, but is not needed otherwise.</P>
<P>Oligohydramnios is a condition where too little fluid surrounds the baby in the womb (uterus). Oligohydramnios does not seem to affect some babies, but others may show signs of distress, such as unusual heart rates or the passing of a bowel motion (meconium). Oligohydramnios can be relieved by injections of extra liquid (salt or ringers lactate solution) through the woman's vagina or abdomen into the womb (amnioinfusion). The review of one trial, involving 116 women, found that amnioinfusion for oligohydramnios helps when the baby shows signs of distress. If the baby shows no signs of distress from oligohydramnios, then amnioinfusion is not helpful.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2012-02-28 13:43:29 +0000" MODIFIED_BY="Sonja L  Henderson">
<ABS_BACKGROUND>
<P>Amnioinfusion aims to relieve umbilical cord compression during labour by infusing a liquid into the uterine cavity. </P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2010-06-03 16:51:46 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>The objective of this review was to assess the effects of prophylactic amnioinfusion for women in labour with oligohydramnios, but not fetal heart deceleration, compared with therapeutic amnioinfusion only if fetal heart rate decelerations or thick meconium-staining of the liquor occur.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2012-02-28 13:43:29 +0000" MODIFIED_BY="Lynn Hampson">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (28 February 2012).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2010-05-25 14:45:18 +0100" MODIFIED_BY="Lynn Hampson">
<P>Randomised trials comparing prophylactic amnioinfusion in women in labour with oligohydramnios but not fetal heart rate deceleration in labour with therapeutic amnioinfusion.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2010-06-03 16:51:57 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>The authors assessed trial quality and extracted data.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2010-06-03 16:56:10 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>One randomized trial of 116 women was included. No differences were found in the rate of caesarean section (risk ratio 1.29, 95% confidence interval 0.60 to 2.74). There were no differences in cord arterial pH, oxytocin augmentation, neonatal pneumonia or postpartum endometritis. Prophylactic amnioinfusion was associated with increased intrapartum fever (risk ratio 3.48, 95% confidence interval 1.21 to 10.05).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2010-03-28 04:11:14 +0100" MODIFIED_BY="[Empty name]">
<P>There appears to be no advantage of prophylactic amnioinfusion over therapeutic amnioinfusion carried out only when fetal heart rate decelerations or thick meconium-staining of the liquor occur.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2012-08-08 09:36:16 +0100" MODIFIED_BY="Sonja L  Henderson">
<BACKGROUND MODIFIED="2010-06-04 10:33:25 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>Amnioinfusion for oligohydramnios has been used both prophylactically and therapeutically. It has been found to be effective in reducing fetal heart rate deceleration and caesarean section rate (<LINK REF="REF-Abdel_x002d_Aleem-2005" TYPE="REFERENCE">Abdel-Aleem 2005</LINK>; <LINK REF="REF-Amin-2003" TYPE="REFERENCE">Amin 2003</LINK>; <LINK REF="REF-Persson_x002d_Kjerstadius-1999" TYPE="REFERENCE">Persson-Kjerstadius 1999</LINK>). It has been described as a method of preventing or relieving umbilical cord compression during labour (<LINK REF="REF-Miyazaki-1983" TYPE="REFERENCE">Miyazaki 1983</LINK>). Saline or Ringer's lactate is infused transcervically through a catheter into the uterine cavity or transabdominally through a "spinal" needle when membranes are intact.</P>
<P>In a study conducted in monkeys, removal of amniotic fluid resulted in variable decelerations and saline amnioinfusion relieved the decelerations (<LINK REF="REF-Gabbe-1976" TYPE="REFERENCE">Gabbe 1976</LINK>). The fetal heart rate abnormalities are considered to be due often to umbilical cord compression particularly when there is oligohydramnios.</P>
<P>Readers are referred to reviews of the subject (<LINK REF="REF-Lameier-1993" TYPE="REFERENCE">Lameier 1993</LINK>; <LINK REF="REF-Hofmeyr-1996" TYPE="REFERENCE">Hofmeyr 1996</LINK>). In a randomised trial, a decrease in caesarean section rate in nulliparous women in labour with cord compression heart rate pattern was found in women who had amnioinfusion <LINK REF="REF-Miyazaki-1985" TYPE="REFERENCE">Miyazaki 1985</LINK>. Nageotte noted that amnioinfusion resulted in significantly reduced frequency and severity of decelerations of the fetal heart in labour (<LINK REF="REF-Nageotte-1991" TYPE="REFERENCE">Nageotte 1991</LINK>). On the basis of the outcome of earlier studies on amnioinfusion, amnioinfusion either transcervically or transabdominally has been used in the dilution of thick meconium, treatment of abnormal fetal heart rate patterns and prophylactically or therapeutically in cases of oligohydramnios resulting from rupture of membranes.</P>
<P>An important question arising from these findings is whether prophylactic amnioinfusion has any advantage over a policy of using amnioinfusion only therapeutically when fetal heart rate decelerations or meconium-stained liquor occur.</P>
</BACKGROUND>
<OBJECTIVES>
<P>To assess, from the best available evidence, the effect on maternal and perinatal outcome of prophylactic amnioinfusion for oligohydramnios versus therapeutic amnioinfusion only if fetal heart rate decelerations or heavy meconium-staining of the liquor occur.</P>
</OBJECTIVES>
<METHODS MODIFIED="2012-08-08 09:36:16 +0100" MODIFIED_BY="Sonja L  Henderson">
<SELECTION_CRITERIA MODIFIED="2010-06-03 17:03:54 +0100" MODIFIED_BY="Sonja L  Henderson">
<CRIT_STUDIES MODIFIED="2010-06-03 17:00:08 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>All published, unpublished and ongoing randomised controlled trials comparing prophylactic amnioinfusion for oligohydramnios versus therapeutic amnioinfusion for fetal heart rate decelerations or meconium-stained liquor. We excluded quasi-randomised trials (for example, those randomised by date of birth or hospital number) from the analysis.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2010-03-27 23:23:35 +0000" MODIFIED_BY="[Empty name]">
<P>Women in labour with oligohydramnios but not fetal heart rate decelerations.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2010-06-03 17:00:17 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>Prophylactic amnioinfusion compared with selective (therapeutic) amnioinfusion only for women who develop fetal heart rate decelerations or meconium-stained liquor.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2010-06-03 17:03:54 +0100" MODIFIED_BY="Sonja L  Henderson">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2010-06-03 17:03:43 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>1. Caesarean section rate.<BR/>2. Five minute Apgar score less than 7.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2010-06-03 17:03:54 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>3. Caesarean section rate for fetal distress.<BR/>4. Rate of instrumental deliveries.<BR/>4. Intrapartum fever.<BR/>5. Oxytocin augmentation.<BR/>6. Postpartum endometritis.<BR/>7. Cord arterial pH less than 7.2.<BR/>8. Meconium aspiration.<BR/>9. Neonatal pneumonia.<BR/>10. Neonatal sepsis.</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2012-02-28 13:44:09 +0000" MODIFIED_BY="Lynn Hampson">
<ELECTRONIC_SEARCHES MODIFIED="2012-02-28 13:44:09 +0000" MODIFIED_BY="Lynn Hampson">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (28 February 2012).</P>
<P>The Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from:</P>
<OL>
<LI>quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE;  </LI>
<LI>weekly searches of EMBASE;                        </LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.</LI>
</OL>
<P>Details of the search strategies for CENTRAL, MEDLINE and EMBASE, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the &#8216;Specialized Register&#8217; section within the editorial information about the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/preg/frame.html">Cochrane Pregnancy and Childbirth Group</A>. </P>
<P>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co-ordinator searches the register for each review using the topic list rather than keywords. </P>
<P>We did not apply any language restrictions.</P>
</ELECTRONIC_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2012-08-08 09:36:16 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>We evaluated trials under consideration for methodological quality and appropriateness for inclusion according to the prestated selection criteria, without consideration of their results. We included individual outcome data in the analysis if they met the prestated criteria in <LINK TAG="CRIT_OUTCOMES" TYPE="SECTION">Types of outcome measures</LINK>. We processed included trial data as described in <LINK REF="REF-Clarke-2000" TYPE="REFERENCE">Clarke 2000</LINK>.</P>
<P>We extracted data from the sources and entered them onto the Review Manager computer software (<LINK REF="REF-RevMan-2008" TYPE="REFERENCE">RevMan 2008</LINK>), checked them for accuracy, and analysed them as above using <LINK REF="REF-RevMan-2008" TYPE="REFERENCE">RevMan 2008</LINK>. For dichotomous data, we calculated risk ratios and 95% confidence intervals and, in the absence of heterogeneity, results were pooled using a fixed-effects model. We pooled continuous data using mean differences and 95% confidence intervals.</P>
<STUDY_SELECTION MODIFIED="2010-06-03 17:06:58 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>Two review authors independently assessed for inclusion all the potential studies we identified as a result of the search strategy. We resolved any disagreement through discussion or, if required, consulted a third author.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2010-03-02 13:32:49 +0000" MODIFIED_BY="[Empty name]">
<P>We designed a form to extract data. For eligible studies, two review authors will extract the data using the agreed form. We resolved discrepancies through discussion or, if required, we will consult a third author. Data were entered into Review Manager software (<LINK REF="REF-RevMan-2008" TYPE="REFERENCE">RevMan 2008</LINK>) and checked for accuracy.</P>
<P>When information regarding any of the above was unclear, we attempted to contact authors of the original reports to provide further details.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2012-08-08 09:36:16 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>Two review authors will independently assess risk of bias for each study using the criteria outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>). Any disagreement will be resolved by discussion or by involving a third assessor.</P>
<SUBSECTION>
<HEADING LEVEL="4">(1) Sequence generation (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups.</P>
<P>We assessed the method as:</P>
<UL>
<LI>low risk of bias (any truly random process, e.g. random number table; computer random number generator);</LI>
<LI>high risk of bias (any non random process, e.g. odd or even date of birth; hospital or clinic record number); or</LI>
<LI>unclear risk of bias.   </LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4"> (2) Allocation concealment (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to conceal the allocation sequence in sufficient detail and determine whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);</LI>
<LI>high risk of bias (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);</LI>
<LI>unclear risk of bias.   </LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3) Blinding (checking for possible performance bias)</HEADING>
<P>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. Studies were judged at low risk of bias if they were blinded or if we judged that the lack of blinding could not have affected the results. Blinding was assessed separately for different outcomes or classes of outcomes.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low, high or unclear risk of bias for participants;</LI>
<LI>low, high or unclear risk of bias for personnel;</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(4) Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations)</HEADING>
<P>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes.  Where sufficient information is reported, or can be supplied by the trial authors, we would re-include missing data in the analyses which we undertake. The cut-off point of 20% is used for missing data. We assessed methods as:</P>
<UL>
<LI>low risk of bias;</LI>
<LI>high risk of bias:</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(5) Selective reporting bias</HEADING>
<P>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (where it is clear that all of the study&#8217;s pre-specified outcomes and all expected outcomes of interest to the review have been reported);</LI>
<LI>high risk of bias (where not all the study&#8217;s pre-specified outcomes have been reported; one or more reported primary outcomes were not pre-specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(6) Other sources of bias</HEADING>
<P>We described for each included study any important concerns we have about other possible sources of bias (related to the study design, data-dependent process, extreme baseline disbalance).</P>
<P>We assessed whether each study was free of other problems that could put it at risk of bias:</P>
<UL>
<LI>low risk of bias;</LI>
<LI>high risk of bias;</LI>
<LI>unclear whether there is risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(7) Overall risk of bias</HEADING>
<P>We made explicit judgements about whether studies are at high risk of bias, according to the criteria given in the Handbook (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we consider it is likely to impact on the findings.  In future updates we will explore the impact of the level of bias through undertaking sensitivity analyses - <I>see </I>
<LINK TAG="SENSITIVITY_ANALYSIS" TYPE="SECTION">Sensitivity analysis</LINK>. </P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2010-06-04 10:21:00 +0100" MODIFIED_BY="Sonja L  Henderson">
<SUBSECTION>
<HEADING LEVEL="4">
<I>Dichotomous data</I>
</HEADING>
<P>For dichotomous data, we present results as summary risk ratio with 95% confidence intervals.<I> </I>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">
<I>Continuous data</I>
</HEADING>
<P>For continuous data, we would use the mean difference if outcomes are measured in the same way between trials. We would use the standardised mean difference to combine trials that measure the same outcome, but use different methods. <B> </B>
</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2010-06-04 10:45:53 +0100" MODIFIED_BY="Sonja L  Henderson">
<SUBSECTION>
<HEADING LEVEL="4">Cluster-randomised trials</HEADING>
<P>If identified, we will include cluster-randomised trials in the analyses along with individually randomised trials. We will adjust their sample sizes using the methods described in <LINK REF="REF-Gates-2005" TYPE="REFERENCE">Gates 2005</LINK> using an estimate of the intra-cluster correlation co-efficient (ICC) derived from the trial (if possible), or from another source. If ICCs from other sources are used, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster-randomised trials and individually-randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely.</P>
<P>We will also acknowledge heterogeneity in the randomisation unit and perform a separate meta-analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Crossover trials</HEADING>
<P>If we identify any crossover trials on this topic, and such trials are deemed eligible for inclusion, they will be included in the analyses with parallel group trials, using methods described by<B> </B>
<LINK REF="REF-Elbourne-2002" TYPE="REFERENCE">Elbourne 2002</LINK>
<B>.</B>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Multi-armed trials</HEADING>
<P>When analysing multi-armed trials we would combine all relevant experimental intervention groups of the study into a single group and all relevant control intervention groups into a single control group. If one of the arms is considered irrelevant by the authors it will be excluded from the analysis.<B> </B>
</P>
</SUBSECTION>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2010-06-04 10:23:09 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>For included studies in future updates, we will note levels of attrition. We will explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis.</P>
<P>For all outcomes, we will carry out analyses, as far as possible, on an intention-to-treat basis, i.e. we will attempt to include all participants randomised to each group in the analyses. The denominator for each outcome in each trial will be the number randomised minus any participants whose outcomes are known to be missing.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2010-06-04 10:23:52 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>We would use the I² statistic to measure heterogeneity among the trials in each analysis. In subsequent updates, if we identify substantial heterogeneity (more than 50%), we will explore it by prespecified subgroup analysis.<B> </B>
</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2010-06-04 10:13:12 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>Where we suspect reporting bias (<I>see</I> &#8216;Selective reporting bias&#8217; above), we would attempt to contact study authors asking them to provide missing outcome data. Where this is not possible, and the missing data are thought to introduce serious bias, we would explore the impact of including such studies in the overall assessment of results by a sensitivity analysis<B>. </B>
</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2010-06-04 10:26:12 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>We would carry out statistical analysis using the Review Manager software (<LINK REF="REF-RevMan-2008" TYPE="REFERENCE">RevMan 2008</LINK>). We would use fixed-effect inverse variance meta-analysis for combining data where trials are examining the same intervention, and the trials&#8217; populations and methods are judged sufficiently similar. Where we suspect clinical or methodological heterogeneity between studies sufficient to suggest that treatment effects may differ between trials, we would use random-effects meta-analysis.</P>
<P>If substantial heterogeneity is identified in a fixed-effect meta-analysis, we would note this and repeat the analysis using a random-effects method.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2010-06-07 09:57:44 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>We plan to carry out the following subgroup analyses:</P>
<P>1.     Women in labour with olygohydramnios undergoing prophylactic and therapeutic amnioinfusion for fetal heart decelerations.<BR/>2.     Women in labour with olygohydramnios undergoing prophylactic and therapeutic amnioinfusion for meconium-stained liquor.</P>
<P>The following outcomes will be used in subgroup analysis:</P>
<P>1. Caesarean section rate.<BR/>2. Five-minute Apgar score less than 7.</P>
<P>For fixed-effect meta-analyses, we would conduct planned subgroup analyses classifying whole trials by interaction tests as described by <LINK REF="REF-Deeks-2001" TYPE="REFERENCE">Deeks 2001</LINK>. For random-effects meta-analyses, we would assess differences between subgroups by inspection of the subgroups&#8217; confidence intervals; non-overlapping confidence intervals indicate a statistically significant difference in treatment effect between the subgroups.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2010-06-04 10:08:54 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>In future updates we will perform sensitivity analyses for aspects of the review that might affect the results; for example, where there is a risk of bias associated with the quality of some of the included trials; or to explore the effects of fixed- or random-effects analyses for outcomes with statistical heterogeneity; and to explore the effects of any assumptions made, such as the value of the ICC used for cluster-randomised trials.</P>
<P>Sensitivity analysis will be performed for the primary outcomes (caesarean section rate and five-minute Apgar score less than 7).</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2010-06-04 10:15:41 +0100" MODIFIED_BY="Sonja L  Henderson">
<STUDY_DESCRIPTION MODIFIED="2010-03-28 00:51:48 +0000" MODIFIED_BY="[Empty name]">
<P>One randomised controlled trial of 116 women was included (<LINK REF="STD-Ogundipe-1994" TYPE="STUDY">Ogundipe 1994</LINK>). Sealed opaque envelopes ordered by random number table were used to allocate 56 women with amniotic fluid index of 5cm or less to receive prophylactic amnioinfusion (600ml followed by 3ml per minute), and 60 to a therapeutic amnioinfusion group. </P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2010-06-04 10:15:19 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>The included study (<LINK REF="STD-Ogundipe-1994" TYPE="STUDY">Ogundipe 1994</LINK>) appears methodologically sound, except that the blinding was not done. Analysis was by intention to treat. Of the prophylactic amnioinfusion group, six women progressed too rapidly to receive amnioinfusion. Thirteen women (22%) in the control group developed moderate to severe variable decelerations and received therapeutic amnioinfusion.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2010-06-04 10:15:41 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>No significant differences in maternal or neonatal outcomes were found between prophylactic amnioinfusion and therapeutic amnioinfusion for fetal decelerations in women with oligohydramnios in labour based on one small randomized trial (<LINK REF="STD-Ogundipe-1994" TYPE="STUDY">Ogundipe 1994</LINK>).</P>
<P>The caesarean section rate did not differ between the groups (one study, 116 patients, risk ratio (RR) 1.29, 95% confidence interval (CI) 0.60 to 2.74). The prophylactic amnioinfusion group had a significantly higher incidence of intrapartum fever (one study, 116 patients, RR 3.48, 95% CI 1.21 to 10.05). The incidence of postpartum endometritis did not differ between the groups (one study, 116 women, RR 3.21, 95% CI 0.34 to 30.00). The rate of neonatal sepsis and neonatal pneumonia did not differ between the groups (one study, 116 patients, RR 0.36, 95% CI 0.01 to 8.58; RR 5.35, 95% CI 0.26 to 109.08), respectively) (<LINK REF="STD-Ogundipe-1994" TYPE="STUDY">Ogundipe 1994</LINK>).</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2010-06-04 10:16:00 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>The results show no benefit for prophylactic amnioinfusion over a policy of withholding amnioinfusion unless fetal heart rate decelerations or thick meconium staining of the amniotic fluid occur. The finding of increased intrapartum pyrexia in the included study (<LINK REF="STD-Ogundipe-1994" TYPE="STUDY">Ogundipe 1994</LINK>) is consistent with the finding of a trend to increased intrapartum pyrexia with amnioinfusion in one study (<LINK REF="REF-Strong-1990" TYPE="REFERENCE">Strong 1990</LINK>) of amnioinfusion for cord compression (<LINK REF="REF-Hofmeyr-1998" TYPE="REFERENCE">Hofmeyr 1998</LINK>). However, the pathogenesis of the pyrexia may be by a mechanism other than infection, as puerperal infection has been reduced with amnioinfusion in studies of amnioinfusion for cord compression or potential amnionitis (<LINK REF="REF-Hofmeyr-1998" TYPE="REFERENCE">Hofmeyr 1998</LINK>).</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2010-06-03 17:28:06 +0100" MODIFIED_BY="Sonja L  Henderson">
<IMPLICATIONS_PRACTICE MODIFIED="2010-06-03 17:28:06 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>The findings of the one randomized trial reviewed do not support the use of amnioinfusion prophylactically for oligohydramnios alone, rather than therapeutically only when fetal heart rate decelerations (or thick meconium staining of the amniotic fluid) occur. Given that amnioinfusion is an invasive and uncomfortable procedure, and the uncertainty concerning the possibility of rare maternal complications (<LINK REF="REF-Hofmeyr-1996" TYPE="REFERENCE">Hofmeyr 1996</LINK>; <LINK REF="REF-Wegnelius-1996" TYPE="REFERENCE">Wegnelius 1996</LINK>), prophylactic amnioinfusion for oligohydramnios alone does not appear to be justified in routine clinical practice.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2010-03-28 00:53:22 +0000" MODIFIED_BY="[Empty name]">
<P>Future randomized trials of amnioinfusion for intrapartum oligohydramnios should seek to identify specific categories of women who may benefit from amnioinfusion.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2010-05-13 17:39:49 +0100" MODIFIED_BY="[Empty name]">
<P>The Cochrane Pregnancy and Childbirth Group team for technical support.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2010-06-07 09:54:14 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>Justus Hofmeyr prepared the original review and participated in the preparation of the updated version. Natalia Novikova and Justus Hofmeyr prepared the updated version of the review. George Essilfie-Appiah commented on the updated version.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2010-06-04 10:35:49 +0100" MODIFIED_BY="Sonja L  Henderson">
<STUDIES MODIFIED="2010-05-25 14:52:49 +0100" MODIFIED_BY="Lynn Hampson">
<INCLUDED_STUDIES MODIFIED="2010-05-25 14:52:41 +0100" MODIFIED_BY="Lynn Hampson">
<STUDY DATA_SOURCE="PUB" ID="STD-Ogundipe-1994" MODIFIED="2010-05-25 14:52:41 +0100" MODIFIED_BY="Lynn Hampson" NAME="Ogundipe 1994" YEAR="1994">
<REFERENCE MODIFIED="2010-05-25 14:52:41 +0100" MODIFIED_BY="Lynn Hampson" NOTES="&lt;p&gt;[7476]&lt;/p&gt;" NOTES_MODIFIED="2010-05-25 14:52:41 +0100" NOTES_MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ogundipe OA, Spong CY, Ross MG</AU>
<TI>Prophylactic amnioinfusion for oligohydramnios in term labor: a risk for chorioamnionitis</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1993</YR>
<VL>168</VL>
<NO>1 Pt 2</NO>
<PG>363</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-08-03 22:16:03 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[8696]&lt;/p&gt;" NOTES_MODIFIED="2009-08-03 22:16:03 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ogundipe OA, Spong CY, Ross MG</AU>
<TI>Prophylactic amnioinfusion for oligohydramnios: a re-evaluation</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1994</YR>
<VL>84</VL>
<PG>544-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2010-05-25 14:52:49 +0100" MODIFIED_BY="Lynn Hampson">
<STUDY DATA_SOURCE="PUB" ID="STD-Cook-1993" MODIFIED="2010-05-25 14:52:49 +0100" MODIFIED_BY="Lynn Hampson" NAME="Cook 1993" YEAR="2003">
<REFERENCE MODIFIED="2010-05-25 14:52:49 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cook V, Spinnato JA.</AU>
<TI>Prophylactic vs therapeutic amnioinfusion</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1993</YR>
<VL>168</VL>
<NO>1 Pt 2</NO>
<PG>363</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2010-05-15 14:13:17 +0100" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2010-06-04 10:35:49 +0100" MODIFIED_BY="Sonja L  Henderson">
<ADDITIONAL_REFERENCES MODIFIED="2010-06-04 10:35:49 +0100" MODIFIED_BY="Sonja L  Henderson">
<REFERENCE ID="REF-Abdel_x002d_Aleem-2005" MODIFIED="2010-05-25 14:37:49 +0100" MODIFIED_BY="Lynn Hampson" NAME="Abdel-Aleem 2005" TYPE="JOURNAL_ARTICLE">
<AU>Abdel-Aleem H, Amin AF, Shokry M, Radwan RA</AU>
<TI>Therapeutic amnioinfusion for intrapartum fetal distress using a pediatric feeding tube</TI>
<SO>International Journal of Gynecology &amp; Obstetrics</SO>
<YR>2005</YR>
<VL>90</VL>
<NO>2</NO>
<PG>94-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Amin-2003" MODIFIED="2010-05-25 14:37:49 +0100" MODIFIED_BY="Lynn Hampson" NAME="Amin 2003" TYPE="JOURNAL_ARTICLE">
<AU>Amin AF, Mohammed MS, Sayed GH, Abdel-Razik S</AU>
<TI>Prophylactic transcervical amnioinfusion in laboring women with oligohydramnios</TI>
<SO>International Journal of Gynecology &amp; Obstetrics</SO>
<YR>2003</YR>
<VL>81</VL>
<NO>2</NO>
<PG>183-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Clarke-2000" MODIFIED="2009-08-03 22:21:08 +0100" MODIFIED_BY="[Empty name]" NAME="Clarke 2000" NOTES="&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2009-08-03 22:21:08 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Clarke M, Oxman AD, editors</AU>
<TI>Cochrane Reviewers&#8217; Handbook 4.1 [updated July 2000]</TI>
<SO>In: Review Manager (RevMan) [Computer program]. Version 4.1. Oxford, England: The Cochrane Collaboration, 2000</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deeks-2001" MODIFIED="2009-09-08 09:05:43 +0100" MODIFIED_BY="[Empty name]" NAME="Deeks 2001" TYPE="BOOK_SECTION">
<AU>Deeks JJ, Altman DG, Bradburn MJ</AU>
<TI>Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis</TI>
<SO>Systematic reviews in health care: meta-analysis in context</SO>
<YR>2001</YR>
<ED>Egger M, Davey Smith G, Altman DG</ED>
<PB>BMJ Books</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Elbourne-2002" MODIFIED="2009-09-08 09:05:43 +0100" MODIFIED_BY="[Empty name]" NAME="Elbourne 2002" TYPE="JOURNAL_ARTICLE">
<AU>Elbourne DR, Altman DG, Higgins JPT, Curtin F, Vaillancourt JM</AU>
<TI>Meta-analyses involving cross-over trials: methodological issues</TI>
<SO>International Journal of Epidemiology</SO>
<YR>2002</YR>
<VL>31</VL>
<PG>140-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gabbe-1976" MODIFIED="2009-08-03 22:24:07 +0100" MODIFIED_BY="[Empty name]" NAME="Gabbe 1976" TYPE="JOURNAL_ARTICLE">
<AU>Gabbe SG, Ettinger BB, Freeman RK, Martin CB</AU>
<TI>Umbilical cord compression associated with amniotomy: laboratory observations</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1976</YR>
<VL>126</VL>
<PG>353-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gates-2005" MODIFIED="2010-06-04 10:35:49 +0100" MODIFIED_BY="Sonja L  Henderson" NAME="Gates 2005" TYPE="OTHER">
<AU>Gates S</AU>
<TI>Methodological Guidelines</TI>
<SO>In: The Editorial Team. Pregnancy and Childbirth Group. About The Cochrane Collaboration (Collaborative Review Groups (CRGs)) 2005, Issue 2</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2009-09-08 09:05:57 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2008" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008</TI>
<SO>Available from www.cochrane-handbook.org.</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hofmeyr-1998" MODIFIED="2010-05-25 14:48:48 +0100" MODIFIED_BY="Lynn Hampson" NAME="Hofmeyr 1998" TYPE="COCHRANE_REVIEW">
<AU>Hofmeyr GJ</AU>
<TI>Amnioinfusion for potential or suspected umbilical cord compression in labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1998</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2009-08-03 22:18:30 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-08-03 22:18:30 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000013"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lameier-1993" MODIFIED="2009-08-03 22:24:25 +0100" MODIFIED_BY="[Empty name]" NAME="Lameier 1993" TYPE="JOURNAL_ARTICLE">
<AU>Lameier LN, Katz VL</AU>
<TI>Amnioinfusion: a review</TI>
<SO>Obstetrical and Gynecological Survey</SO>
<YR>1993</YR>
<VL>48</VL>
<PG>829-37</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Miyazaki-1983" MODIFIED="2009-08-03 22:24:53 +0100" MODIFIED_BY="[Empty name]" NAME="Miyazaki 1983" TYPE="JOURNAL_ARTICLE">
<AU>Miyazaki FS, Taylor NA</AU>
<TI>Saline amnioinfusion for relief of prolonged variable decelerations</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1983</YR>
<VL>146</VL>
<PG>670-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Miyazaki-1985" MODIFIED="2010-03-27 23:10:31 +0000" MODIFIED_BY="[Empty name]" NAME="Miyazaki 1985" TYPE="JOURNAL_ARTICLE">
<AU>Miyazaki FS, Nevarez F.</AU>
<TI>Saline amnioinfusion for relief of repetitive variable decelerations. A prospective randomized study</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1985</YR>
<VL>153</VL>
<PG>301-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nageotte-1991" MODIFIED="2010-06-04 10:32:27 +0100" MODIFIED_BY="Sonja L  Henderson" NAME="Nageotte 1991" TYPE="JOURNAL_ARTICLE">
<AU>Nageotte MP, Bertucci L, Towers CV, Lagrew DL, Modanlou H</AU>
<TI>Prophylactic intrapartum amnioinfusion in pregnancies complicated by oligohydramnios. A prospective study</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>1991</YR>
<VL>77</VL>
<PG>677-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Persson_x002d_Kjerstadius-1999" MODIFIED="2010-05-25 14:37:49 +0100" MODIFIED_BY="Lynn Hampson" NAME="Persson-Kjerstadius 1999" TYPE="JOURNAL_ARTICLE">
<AU>Persson-Kjerstadius N, Forsgren H, Westgren M</AU>
<TI>Intrapartum amnioinfusion in women with oligohydramniosis A prospective randomized trial</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>1999</YR>
<VL>78</VL>
<NO>2</NO>
<PG>116-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Puertas-2001" MODIFIED="2010-05-25 14:37:49 +0100" MODIFIED_BY="Lynn Hampson" NAME="Puertas 2001" TYPE="JOURNAL_ARTICLE">
<AU>Puertas A, Munoz A, Mozas J, Carrillo MP, Perez B, Gonzalez R, et al</AU>
<TI>Value of intrapartum transcervical amnioinfusion in pregnancies with oligoamnios and integral ovular membranes [abstract]</TI>
<SO>Journal of Perinatal Medicine</SO>
<YR>2001</YR>
<VL>29 Suppl 1</VL>
<NO>Pt 2</NO>
<PG>632</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2008" MODIFIED="2010-05-25 14:50:33 +0100" MODIFIED_BY="Lynn Hampson" NAME="RevMan 2008" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2008</YR>
<EN>5.0</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rinehart-2000" MODIFIED="2010-05-25 14:37:49 +0100" MODIFIED_BY="Lynn Hampson" NAME="Rinehart 2000" TYPE="JOURNAL_ARTICLE">
<AU>Rinehart BK, Terrone DA, Barrow JH, Isler CM, Barrilleaux PS, Roberts WE</AU>
<TI>Randomized trial of intermittent or continuous amnioinfusion for variable decelerations</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>2000</YR>
<VL>96</VL>
<NO>4</NO>
<PG>571-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Strong-1990" MODIFIED="2009-08-03 22:25:04 +0100" MODIFIED_BY="[Empty name]" NAME="Strong 1990" TYPE="JOURNAL_ARTICLE">
<AU>Strong TH, Hetzler G, Sarno AP, Paul RH</AU>
<TI>Prophylactic intrapartum amnioinfusion: a randomized clinical trial</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1990</YR>
<VL>162</VL>
<PG>1370-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wegnelius-1996" MODIFIED="2009-08-03 22:25:30 +0100" MODIFIED_BY="[Empty name]" NAME="Wegnelius 1996" TYPE="JOURNAL_ARTICLE">
<AU>Wegnelius G, Bergstrom M, Ahlbom L, Thomassen P</AU>
<TI>A case report of life-threatening pulmonary edema</TI>
<SO>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</SO>
<YR>1996</YR>
<VL>65</VL>
<PG>237-9</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2009-08-03 22:22:02 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Hofmeyr-1995" MODIFIED="2009-08-03 22:21:27 +0100" MODIFIED_BY="[Empty name]" NAME="Hofmeyr 1995" TYPE="OTHER">
<AU>Hofmeyr GJ</AU>
<TI>Prophylactic vs therapeutic amnioinfusion for intrapartum oligohydramnios. [revised 11 January 1995]</TI>
<SO>In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Database of Systematic Reviews [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hofmeyr-1996" MODIFIED="2009-08-03 22:22:02 +0100" MODIFIED_BY="[Empty name]" NAME="Hofmeyr 1996" TYPE="JOURNAL_ARTICLE">
<AU>Hofmeyr GJ, Gulmezoglu AM, Nikodem VC, de Jager M</AU>
<TI>Amnioinfusion</TI>
<SO>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</SO>
<YR>1996</YR>
<VL>64</VL>
<PG>159-65</PG>
<IDENTIFIERS/>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2010-06-07 09:51:48 +0100" MODIFIED_BY="Sonja L  Henderson">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2010-06-04 10:28:27 +0100" MODIFIED_BY="Sonja L  Henderson" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2010-06-04 10:28:27 +0100" MODIFIED_BY="Sonja L  Henderson" STUDY_ID="STD-Ogundipe-1994">
<CHAR_METHODS>
<P>Allocated by consecutive, sealed opaque envelopes previously randomised from a table of random numbers.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-04 10:27:46 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>Inclusion criteria: singleton pregnancy; 36 weeks or more; oligohydramnios (4-quadrant amniotic fluid index 5cm or less).<BR/>Exclusion criteria: variable or late decelerations before study enrolment; fetal anomalies; non-vertex presentation; vaginal bleeding; maternal fever; previous caesarean delivery; unwillingness to participate.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Prophylactic amnioinfusion (with 600ml saline at 20ml per minute followed by 3ml per minute through the first stage of labour) compared with therapeutic amnioinfusion only for recurrent moderate or severe variable decelerations. Intrauterine pressure was checked hourly.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-06-04 10:28:06 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>Oxytocin augmentation; intrapartum fever; caesarean delivery; caesarean section for fetal distress; 1 minute Apgar score &lt; 4; 5 minute Apgar score &lt; 5; meconium aspiration; neonatal pneumonia; neonatal sepsis; umbilical artery pH &lt; 7.2.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-06-04 10:28:27 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>Torrance, California, USA. In the prophylactic amnioinfusion group, 6 of the 56 women progressed too rapidly to receive amnioinfusion. In the control group, 13 of 60 women developed moderate or severe FHR decelerations and received therapeutic amnioinfusion. Women were analysed as originally randomized.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>FHR: fetal heart rate</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2010-06-07 09:51:48 +0100" MODIFIED_BY="Sonja L  Henderson" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2010-06-03 17:29:48 +0100" MODIFIED_BY="Sonja L  Henderson" STUDY_ID="STD-Cook-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-03 17:29:48 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>1. Randomization is unclear.<BR/>2. Definition of oligohydramnios is unconventional (AFI &lt; 5 cm) and different to other trials.<BR/>3. Published only in abstract form with very limited information of the trial details.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>AFI: amniotic fluid index</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2010-05-15 14:13:17 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2010-06-03 17:28:56 +0100" MODIFIED_BY="Sonja L  Henderson">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2010-06-03 17:28:54 +0100" MODIFIED_BY="Sonja L  Henderson" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-03 17:28:54 +0100" MODIFIED_BY="Sonja L  Henderson" RESULT="YES" STUDY_ID="STD-Ogundipe-1994">
<DESCRIPTION>
<P>Randomization from a table of random numbers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2010-06-03 17:28:55 +0100" MODIFIED_BY="Sonja L  Henderson" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-03 17:28:55 +0100" MODIFIED_BY="Sonja L  Henderson" RESULT="YES" STUDY_ID="STD-Ogundipe-1994">
<DESCRIPTION>
<P>Sealed opaque envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2010-03-28 00:39:39 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-03-28 00:39:39 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ogundipe-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2010-06-03 17:28:56 +0100" MODIFIED_BY="Sonja L  Henderson" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-06-03 17:28:56 +0100" MODIFIED_BY="Sonja L  Henderson" RESULT="YES" STUDY_ID="STD-Ogundipe-1994">
<DESCRIPTION>
<P>Data were complete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2010-03-28 00:47:23 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-28 00:47:23 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ogundipe-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2010-03-27 22:44:44 +0000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ogundipe-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2010-06-04 10:21:12 +0100" MODIFIED_BY="Sonja L  Henderson">
<COMPARISON ID="CMP-001" MODIFIED="2010-06-04 10:21:12 +0100" MODIFIED_BY="Sonja L  Henderson" NO="1">
<NAME>Prophylactic vs therapeutic amnioinfusion for intrapartum oligohydramnios</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.3991931774215205" CI_START="0.21265652404904864" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.3800652177513044" LOG_CI_START="-0.6723212891077806" LOG_EFFECT_SIZE="-0.146128035678238" METHOD="MH" MODIFIED="2010-06-04 10:20:06 +0100" MODIFIED_BY="Sonja L  Henderson" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.5862367501866057" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="56" TOTAL_2="60" WEIGHT="100.0" Z="0.5442975279409971">
<NAME>Caesarean for suspected fetal distress</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="2.3991931774215205" CI_START="0.21265652404904864" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3800652177513044" LOG_CI_START="-0.6723212891077806" LOG_EFFECT_SIZE="-0.146128035678238" ORDER="29656" O_E="0.0" SE="0.6181770435262516" STUDY_ID="STD-Ogundipe-1994" TOTAL_1="56" TOTAL_2="60" VAR="0.3821428571428571" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.7384359871829993" CI_START="0.6036515851481645" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2857142857142858" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.4375025934524546" LOG_CI_START="-0.21921365460231843" LOG_EFFECT_SIZE="0.10914446942506807" METHOD="MH" MODIFIED="2010-03-27 22:44:44 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.5147357469939908" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="56" TOTAL_2="60" WEIGHT="100.0" Z="0.6514814573828688">
<NAME>Caesarean, overall</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="2.7384359871829993" CI_START="0.6036515851481645" EFFECT_SIZE="1.2857142857142858" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" LOG_CI_END="0.4375025934524546" LOG_CI_START="-0.21921365460231843" LOG_EFFECT_SIZE="0.10914446942506807" ORDER="29658" O_E="0.0" SE="0.3857583749052298" STUDY_ID="STD-Ogundipe-1994" TOTAL_1="56" TOTAL_2="60" VAR="0.14880952380952384" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.635476083911972E-32" CI_END="3.031907563124241" CI_START="0.24232067180635017" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.857142857142857" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" I2="100.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.481715956380521" LOG_CI_START="-0.6156095356417476" LOG_EFFECT_SIZE="-0.06694678963061328" METHOD="MH" MODIFIED="2010-06-04 10:21:12 +0100" MODIFIED_BY="Sonja L  Henderson" NO="3" P_CHI2="0.0" P_Q="1.0" P_Z="0.8109884230520724" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="56" TOTAL_2="60" WEIGHT="100.0" Z="0.2391510951135706">
<NAME>Cord arterial pH &lt;7.2</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="3.0319075631242423" CI_START="0.24232067180635017" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.4817159563805212" LOG_CI_START="-0.6156095356417476" LOG_EFFECT_SIZE="-0.06694678963061322" ORDER="29663" O_E="0.0" SE="0.6445744258626699" STUDY_ID="STD-Ogundipe-1994" TOTAL_1="56" TOTAL_2="60" VAR="0.4154761904761905" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="10.049048190042843" CI_START="1.2066136661147133" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="3.482142857142857" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="1.0021249288820935" LOG_CI_START="0.08156823983054166" LOG_EFFECT_SIZE="0.5418465843563176" METHOD="MH" MODIFIED="2010-05-15 14:23:33 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.021038154038630654" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="56" TOTAL_2="60" WEIGHT="100.0" Z="2.307299057440131">
<NAME>Intrapartum fever</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="10.049048190042843" CI_START="1.2066136661147133" EFFECT_SIZE="3.482142857142857" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="4" LOG_CI_END="1.0021249288820935" LOG_CI_START="0.08156823983054166" LOG_EFFECT_SIZE="0.5418465843563176" ORDER="29664" O_E="0.0" SE="0.5407395559779841" STUDY_ID="STD-Ogundipe-1994" TOTAL_1="56" TOTAL_2="60" VAR="0.2923992673992674" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.195805445462416" CI_START="0.8835259172971067" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3928571428571428" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="20" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.34159385777022516" LOG_CI_START="-0.05378070640166523" LOG_EFFECT_SIZE="0.14390657568427997" METHOD="MH" MODIFIED="2010-05-15 14:23:33 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.15364996124963787" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="56" TOTAL_2="60" WEIGHT="100.0" Z="1.426756959292168">
<NAME>Oxytocin augmentation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="2.1958054454624163" CI_START="0.8835259172971067" EFFECT_SIZE="1.3928571428571428" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="20" LOG_CI_END="0.3415938577702252" LOG_CI_START="-0.05378070640166523" LOG_EFFECT_SIZE="0.14390657568427997" ORDER="29665" O_E="0.0" SE="0.23224497613022535" STUDY_ID="STD-Ogundipe-1994" TOTAL_1="56" TOTAL_2="60" VAR="0.05393772893772894" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="16.722799685797536" CI_START="0.06864635140301395" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0714285714285714" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="1.2233089875950376" LOG_CI_START="-1.1633825408401512" LOG_EFFECT_SIZE="0.029963223377443202" METHOD="MH" MODIFIED="2010-05-15 14:23:33 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.960750410386585" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="56" TOTAL_2="60" WEIGHT="100.0" Z="0.04921192201073506">
<NAME>1 minute Apgar score &lt;4</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="16.722799685797536" CI_START="0.06864635140301395" EFFECT_SIZE="1.0714285714285714" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2233089875950376" LOG_CI_START="-1.1633825408401512" LOG_EFFECT_SIZE="0.029963223377443202" ORDER="29666" O_E="0.0" SE="1.4019544181164345" STUDY_ID="STD-Ogundipe-1994" TOTAL_1="56" TOTAL_2="60" VAR="1.9654761904761906" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-15 14:23:33 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="56" TOTAL_2="60" WEIGHT="0.0" Z="0.0">
<NAME>5 minute Apgar score &lt;5</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="29667" O_E="0.0" SE="0.0" STUDY_ID="STD-Ogundipe-1994" TOTAL_1="56" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-15 14:23:33 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="56" TOTAL_2="60" WEIGHT="0.0" Z="0.0">
<NAME>Meconium aspiration</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="29668" O_E="0.0" SE="0.0" STUDY_ID="STD-Ogundipe-1994" TOTAL_1="56" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="109.0797550852298" CI_START="0.26248579960606083" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="5.350877192982456" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" I2_Q="100.0" ID="CMP-001.09" LOG_CI_END="2.037744154157265" LOG_CI_START="-0.580894186808676" LOG_EFFECT_SIZE="0.7284249836742944" METHOD="MH" MODIFIED="2010-05-15 14:23:33 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="1.0" P_Q="0.0" P_Z="0.2755352803773594" Q="2.0837912124500545E-32" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="56" TOTAL_2="60" WEIGHT="100.0" Z="1.0904039027505885">
<NAME>Neonatal pneumonia</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="109.0797550852298" CI_START="0.26248579960606083" EFFECT_SIZE="5.350877192982456" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.037744154157265" LOG_CI_START="-0.580894186808676" LOG_EFFECT_SIZE="0.7284249836742944" ORDER="29669" O_E="0.0" SE="1.5382011239522375" STUDY_ID="STD-Ogundipe-1994" TOTAL_1="56" TOTAL_2="60" VAR="2.3660626977279264" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="8.5795943148014" CI_START="0.014832033457694148" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3567251461988304" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="0.9334667527661221" LOG_CI_START="-1.828799303528896" LOG_EFFECT_SIZE="-0.4476662753813868" METHOD="MH" MODIFIED="2010-05-15 14:23:33 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="0.5252441255143154" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="56" TOTAL_2="60" WEIGHT="100.0" Z="0.635282596939676">
<NAME>Neonatal sepsis</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="8.5795943148014" CI_START="0.014832033457694162" EFFECT_SIZE="0.3567251461988304" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9334667527661221" LOG_CI_START="-1.8287993035288956" LOG_EFFECT_SIZE="-0.4476662753813868" ORDER="29670" O_E="0.0" SE="1.6225687549051944" STUDY_ID="STD-Ogundipe-1994" TOTAL_1="56" TOTAL_2="60" VAR="2.632729364394593" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="30.0026130487301" CI_START="0.3443577609817064" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="3.2142857142857144" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="1.4771590808271429" LOG_CI_START="-0.46299012463293154" LOG_EFFECT_SIZE="0.5070844780971057" METHOD="MH" MODIFIED="2010-05-15 14:23:33 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="1.0" P_Q="1.0" P_Z="0.30558658900246183" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="56" TOTAL_2="60" WEIGHT="100.0" Z="1.024526682167146">
<NAME>Postpartum endometritis</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="30.0026130487301" CI_START="0.3443577609817064" EFFECT_SIZE="3.2142857142857144" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4771590808271429" LOG_CI_START="-0.46299012463293154" LOG_EFFECT_SIZE="0.5070844780971057" ORDER="29671" O_E="0.0" SE="1.1396532471807044" STUDY_ID="STD-Ogundipe-1994" TOTAL_1="56" TOTAL_2="60" VAR="1.2988095238095239" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>